Identifikation und Modulation von Resistenzmechanismen gegenüber Rituximab in B-Zell-Non-Hodgkin-LymphomenClaudia Stolz(Essen University Hospital)DuEPublico (University of Duisburg-Essen)March 13, 2009Cited by 0SaveCiteExport RISWatch citationsRelated PapersTargeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis|Blood|2008|91